GMAB earnings call for the period ending March 31, 2020.
News & Analysis: Genmab A/S
GMAB earnings call for the period ending December 31, 2019.
Investing in biotechs is inherently risky. IPOs are too. What does the stock performance of 2019’s biotech IPO class look like so far?